🇺🇸 PFE — Pfizer Inc.

Healthcare Compra
← Volver

Precio actual

28,45 USD

Máx. histórico

61,71

1719 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-53,90%

Rango 52 semanas

23,58 – 29,21

Variación hoy

-1,25%

Cierre anterior

28,81

Rango de hoy

28,38 – 28,69

Volumen hoy

23.529.537

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
37,43 (puede no estar actualizado)
Dividend yield
6,05% (puede no estar actualizado)
Precio objetivo analistas
28,61 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 3 días
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 6,05%
Fecha de pago Importe por participación
07/11/2007 0,2751 USD
08/08/2007 0,2751 USD
09/05/2007 0,2751 USD
07/02/2007 0,2751 USD
08/11/2006 0,2277 USD
09/08/2006 0,2277 USD
10/05/2006 0,2277 USD
08/02/2006 0,2277 USD
08/11/2005 0,1803 USD
10/08/2005 0,1803 USD
11/05/2005 0,1803 USD
09/02/2005 0,1803 USD
09/11/2004 0,1613 USD
11/08/2004 0,1613 USD
12/05/2004 0,1613 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/02/2010 16,99 17,26 16,70 17,04 -0,39% 3,29% 95.279.492
04/02/2010 17,41 17,50 17,09 17,11 -3,17% 2,34% 99.352.043
03/02/2010 17,73 17,88 17,48 17,67 -3,22% 2,30% 120.151.889
02/02/2010 17,90 18,34 17,81 18,25 +2,40% 2,97% 71.262.310
01/02/2010 17,83 18,02 17,74 17,83 +0,70% 1,54% 41.586.308
29/01/2010 17,74 18,00 17,57 17,70 +0,16% 2,41% 59.071.114
28/01/2010 18,09 18,12 17,66 17,68 -1,95% 2,57% 53.690.549
27/01/2010 17,82 18,11 17,70 18,03 +1,17% 2,29% 57.558.308
26/01/2010 17,76 17,93 17,68 17,82 -0,37% 1,44% 45.955.032
25/01/2010 18,25 18,26 17,87 17,88 -0,58% 2,13% 51.933.110
22/01/2010 18,27 18,90 17,93 17,99 -1,46% 5,30% 65.034.962
21/01/2010 19,01 19,12 18,19 18,25 -3,51% 4,89% 81.343.188
20/01/2010 19,02 19,32 18,85 18,92 -0,30% 2,44% 83.522.965
19/01/2010 18,53 19,04 18,50 18,98 +2,62% 2,92% 82.562.244
15/01/2010 18,43 18,67 18,27 18,49 +0,57% 2,16% 80.760.537
14/01/2010 18,22 18,50 18,15 18,39 +0,89% 1,93% 49.820.367
13/01/2010 17,90 18,31 17,90 18,23 +2,34% 2,28% 62.728.072
12/01/2010 17,84 18,02 17,69 17,81 -0,32% 1,86% 43.501.847
11/01/2010 17,87 17,98 17,71 17,87 +0,80% 1,49% 34.199.665
08/01/2010 17,67 17,75 17,57 17,72 +0,81% 1,02% 32.049.716
07/01/2010 17,69 17,71 17,51 17,58 -0,38% 1,13% 41.557.112
06/01/2010 17,70 17,85 17,56 17,65 -0,32% 1,61% 43.640.975
05/01/2010 17,95 17,96 17,60 17,70 -1,43% 2,01% 45.714.931
04/01/2010 17,33 17,97 17,31 17,96 +4,07% 3,83% 54.898.644
31/12/2009 17,45 17,53 17,26 17,26 -1,68% 1,58% 27.063.136
30/12/2009 17,53 17,64 17,44 17,55 -0,32% 1,14% 19.279.663
29/12/2009 17,66 17,75 17,59 17,61 -0,38% 0,91% 20.728.702
28/12/2009 17,72 17,76 17,58 17,68 +0,16% 1,02% 20.499.141
24/12/2009 17,71 17,73 17,56 17,65 +0,11% 0,96% 13.633.806
23/12/2009 17,80 17,84 17,58 17,63 -0,16% 1,44% 29.473.424